HUP0301137A2 - Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same - Google Patents
Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the sameInfo
- Publication number
- HUP0301137A2 HUP0301137A2 HU0301137A HUP0301137A HUP0301137A2 HU P0301137 A2 HUP0301137 A2 HU P0301137A2 HU 0301137 A HU0301137 A HU 0301137A HU P0301137 A HUP0301137 A HU P0301137A HU P0301137 A2 HUP0301137 A2 HU P0301137A2
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- treatment
- pharmaceutical composition
- composition containing
- same
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001467 thiazolidinediones Chemical class 0.000 title 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 2
- MSOPDKKENJARPF-UHFFFAOYSA-N 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrobromide Chemical compound Br.C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O MSOPDKKENJARPF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
A találmány az 5-[4-{2-[N-metil-N-(2-piridil)-amino]-etoxi}-benzil]-2,4-dioxo-tiazolidin-hidrobromidra és szolvátjaira mint újgyógyszerhatóanyagra, a gyógyszerhatóanyag előállítási eljárására, agyógyszerhatóanyagot tartalmazó gyógyszerkészítményekre, valamint agyógyszerhatóanyag gyógyászati alkalmazására vonatkozik. ÓThe invention relates to 5-[4-{2-[N-methyl-N-(2-pyridyl)-amino]-ethoxy}-benzyl]-2,4-dioxo-thiazolidine hydrobromide and its solvates as a new active pharmaceutical ingredient, the preparation of the active pharmaceutical ingredient applies to its procedure, pharmaceutical preparations containing the active medicinal ingredient, and the medicinal use of the active medicinal ingredient. HE
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0014006.1A GB0014006D0 (en) | 2000-06-08 | 2000-06-08 | Novel pharmaceutical |
PCT/GB2001/002567 WO2001094344A1 (en) | 2000-06-08 | 2001-06-08 | Thiazolidinedione salt for treatment of diabetes mellitus |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0301137A2 true HUP0301137A2 (en) | 2003-08-28 |
HUP0301137A3 HUP0301137A3 (en) | 2005-04-28 |
Family
ID=9893257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0301137A HUP0301137A3 (en) | 2000-06-08 | 2001-06-08 | Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1296980A1 (en) |
JP (1) | JP2003535862A (en) |
KR (1) | KR20030007918A (en) |
CN (1) | CN1443186A (en) |
AP (1) | AP2002002673A0 (en) |
AU (1) | AU2001264078A1 (en) |
BG (1) | BG107357A (en) |
BR (1) | BR0111536A (en) |
CA (1) | CA2411065A1 (en) |
CZ (1) | CZ20023966A3 (en) |
DZ (1) | DZ3382A1 (en) |
EA (1) | EA200300005A1 (en) |
GB (1) | GB0014006D0 (en) |
HU (1) | HUP0301137A3 (en) |
IL (1) | IL153279A0 (en) |
MA (1) | MA25753A1 (en) |
MX (1) | MXPA02012100A (en) |
NO (1) | NO20025883L (en) |
OA (1) | OA12284A (en) |
PL (1) | PL360592A1 (en) |
SK (1) | SK17142002A3 (en) |
WO (1) | WO2001094344A1 (en) |
ZA (1) | ZA200209954B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
DE102005034406A1 (en) * | 2005-07-22 | 2007-02-01 | Ratiopharm Gmbh | New salts of rosiglitazone |
US20080176905A1 (en) * | 2007-01-22 | 2008-07-24 | Santiago Ini | Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
EP1956018A1 (en) * | 2007-02-06 | 2008-08-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Method of preparing a derivative of benzimidazole |
US20100056583A1 (en) * | 2008-08-21 | 2010-03-04 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
-
2000
- 2000-06-08 GB GBGB0014006.1A patent/GB0014006D0/en not_active Ceased
-
2001
- 2001-06-08 KR KR1020027016721A patent/KR20030007918A/en not_active Application Discontinuation
- 2001-06-08 CN CN01813190A patent/CN1443186A/en active Pending
- 2001-06-08 BR BR0111536-7A patent/BR0111536A/en not_active IP Right Cessation
- 2001-06-08 SK SK1714-2002A patent/SK17142002A3/en not_active Application Discontinuation
- 2001-06-08 CA CA002411065A patent/CA2411065A1/en not_active Abandoned
- 2001-06-08 WO PCT/GB2001/002567 patent/WO2001094344A1/en not_active Application Discontinuation
- 2001-06-08 IL IL15327901A patent/IL153279A0/en unknown
- 2001-06-08 MX MXPA02012100A patent/MXPA02012100A/en unknown
- 2001-06-08 PL PL36059201A patent/PL360592A1/en not_active Application Discontinuation
- 2001-06-08 OA OA1200200370A patent/OA12284A/en unknown
- 2001-06-08 HU HU0301137A patent/HUP0301137A3/en unknown
- 2001-06-08 EA EA200300005A patent/EA200300005A1/en unknown
- 2001-06-08 EP EP01938400A patent/EP1296980A1/en not_active Withdrawn
- 2001-06-08 DZ DZ013382A patent/DZ3382A1/en active
- 2001-06-08 JP JP2002501893A patent/JP2003535862A/en active Pending
- 2001-06-08 CZ CZ20023966A patent/CZ20023966A3/en unknown
- 2001-06-08 AU AU2001264078A patent/AU2001264078A1/en not_active Abandoned
- 2001-06-08 AP APAP/P/2002/002673A patent/AP2002002673A0/en unknown
-
2002
- 2002-12-04 MA MA26933A patent/MA25753A1/en unknown
- 2002-12-05 BG BG107357A patent/BG107357A/en unknown
- 2002-12-06 NO NO20025883A patent/NO20025883L/en not_active Application Discontinuation
- 2002-12-09 ZA ZA200209954A patent/ZA200209954B/en unknown
Also Published As
Publication number | Publication date |
---|---|
OA12284A (en) | 2003-11-10 |
KR20030007918A (en) | 2003-01-23 |
PL360592A1 (en) | 2004-09-20 |
JP2003535862A (en) | 2003-12-02 |
EA200300005A1 (en) | 2003-04-24 |
CN1443186A (en) | 2003-09-17 |
BG107357A (en) | 2003-08-29 |
MXPA02012100A (en) | 2003-04-25 |
EP1296980A1 (en) | 2003-04-02 |
MA25753A1 (en) | 2003-04-01 |
NO20025883D0 (en) | 2002-12-06 |
IL153279A0 (en) | 2003-07-06 |
AP2002002673A0 (en) | 2002-12-31 |
CA2411065A1 (en) | 2001-12-13 |
AU2001264078A1 (en) | 2001-12-17 |
WO2001094344A1 (en) | 2001-12-13 |
BR0111536A (en) | 2003-07-01 |
NO20025883L (en) | 2003-02-03 |
HUP0301137A3 (en) | 2005-04-28 |
GB0014006D0 (en) | 2000-08-02 |
DZ3382A1 (en) | 2001-12-13 |
SK17142002A3 (en) | 2003-10-07 |
CZ20023966A3 (en) | 2003-04-16 |
ZA200209954B (en) | 2003-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0204122A2 (en) | Novel composition based on a thiazolidinedione and metformin and its use | |
DE60220055D1 (en) | 4- (4-METHOXYBENZYL) -N '- (5-NITRO-1,3-THIAZOLE-2-YL) UREA AND ITS USE IN THE TREATMENT OF GLYCOGENSYNTHASEKINASE-3 (GSK3) ASSOCIATED SUFFERING | |
AR015894A1 (en) | USE OF 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] TIAZOLIDIN-2,4-DIONA AND INSULIN FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINS SUCH COMPOUNDS | |
HUP0301137A2 (en) | Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same | |
HUP0300777A2 (en) | Tartrate salt of thiazolidinedione derivative | |
HUP9802897A2 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
AR045230A1 (en) | ORAL DOSAGE FORM INCLUDING 5- [4- [2- (N-METHYL-N- (2- PIRIDIL) -AMINO) -ETOXI] -BENCIL] -TIAZOLIDINO-2,4-DIONA AND ANOTHER ADDITIONAL ANTI-DIABETIC AGENT; PROCEDURE FOR THE PREPARATION AND USE OF 5- [4- [2- (METIL-N- (2-PIRIDIL) -AMINO) -ETOXI] - BENCIL] - TIAZOLIDINO-2,4-DIONA AND ANOTHER ANTIDIABETIC AGENT | |
HUP0300938A2 (en) | The hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione | |
HUP0300770A2 (en) | Tartrate salt of thiazolidinedione derivative | |
HUP0300778A2 (en) | Tartrate sal of thiazolidinedione derivative | |
EA200101101A1 (en) | NEW PHARMACEUTICAL PREPARATION | |
HUP0301799A2 (en) | Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide for treating diabetes mellitus, process for preparation thereof and pharmaceutical composition containing the same | |
HUP0402092A2 (en) | Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts for preparation of pharmaceutical compositions | |
HUP0300724A2 (en) | Tartrate salt of thiazolidinedione derivative | |
PT1446404E (en) | EDISILATES OF ROSIGLITAZONE AND ITS USE AS ANTIDIABETICS | |
HUP0301188A2 (en) | Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, process for their preparation and pharmaceutical compositions containing them | |
HUP0301199A2 (en) | A dioxo-thiazolidinedione and its use as antidiabetic | |
GB0021784D0 (en) | Novel pharmaceutical | |
DK1315721T3 (en) | A thiazolidinedione derivative and its use as an antidiabetic agent | |
DK1448559T3 (en) | 5- (4- (2- (N-methyl-N- (2-pyridyl) amino) ethoxy) benzyl) thiazolodin-2,4-dionbenzensulfat; process for its preparation; polymorphs i, II and III thereof; and its use as a pharmaceutically active ingredient | |
ECSP003434A (en) | NEW COMPOUNDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |